Industry Symposium World Congress Tissue Engineering and Regenerative Medicine International Society Vienna, Austria September 5-8, 2012 Organized by TERMIS-AM.

Slides:

Advertisements

Similar presentations

Heart Failure and Transplant Medicine Council Immediate Past Chair: David A. Baran, MD Chair: Lee R. Goldberg, MD, MPH Vice-Chair Elect Brad Dyke MD.

Advertisements

Innovative Practice In Using ICT Working Together To Improve The Patient Journey Dr Roy Harper Consultant Physician and Endocrinologist The Ulster Hospital.

West Midlands Academic Health Science Network

West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.

West Midlands Academic Health Science Network

We need user-led research more now than ever before…

Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.

The Graduate School Research, Training and Innovation Interim Dean Dwayne Godwin, PhD Biomedical Sciences.

1 Charlie Campion Technology Development Manager, Biosurgery R&D, Baxter Healthcare Corp. ApaTech as an example of how “academia / industry partnerships”

Vienna, Austria September 5-8, 2012 Industry Day Symposium SESSION 2:

1 Confidential Science of Stem Cells and Potential Applications Andrea Hunt February 22, 2008.

“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.

Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.

CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.

Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.

BREAK. DISCUSSION: In what ways can life-space and academic planning support community life at UC?

College Strategic Plan by Strategic Planning and Quality Assurance Committee.

Building a Community of Innovation and Commercialization: The BEACON Model Presentation to UConn Engineering Department April 29, 2010.

Signature Research and Academic Collaborations Status Report to RHEDC February 15, 2007.

Institute of Cancer Research - Institut du cancer ICR’s Activities in Cancer Imaging.

Drug Discovery Exchange Fellowship Workshop 9 th -10 th December Mike Hardman IMI EMTRAIN Coordinator.

Stuart D. Cook, M.D. Master Educators’ Guild A Commitment to Excellence in Education at UMDNJ Nicholas M. Ponzio, Ph.D. Professor of Pathology and Laboratory.

John McDougall, President 10 th Annual Re$earch Money Conference, 11 May 2011.

Class of 2013 Fellows May 20, 2013 Sheraton Boston Hotel Boston, MA USA.

Mentoring Professor Elizabeth Simpson OBE FRS FMedSci Emeritus Professor of Transplantation Biology, Imperial College London Colby Benari Programme Officer,

Leadership and Advocacy for Medical and Biological Engineering La Raison d’etre pour AIMBE Raphael C. Lee, MD, ScD, DSc(Hon), FACS President, AIMBE.

Teams and the Learning Healthcare System King C. Li, MD, FRCP(C), MBA Senior Associate Dean, Clinical and Translational Research Isadore Meschan Distinguished.

1 Richard Carter Head of Industry Sponsorship Department of Health London.

Progress in the RNOH-IOMS Joint Academic Strategy David Marsh Professor of Clinical Orthopaedics, Institute of Orthopaedics and Musculoskeletal Science.

The Regional Platform for Access and Innovation for Health Analía Porrás Medicines and Health Technologies (HSS/MT) Health Systems based on Primary Health.

PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007

Medicines Optimisation Tony Jamieson Clinical Lead for Medicines 13/07/2015.

Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,

Mary Manning, Executive Director. Getting started The Academy of Medical Sciences: who we are Getting started on policy work Governance Selecting topics.

1 College of Pharmacy. The mission of the University of Michigan, College of Pharmacy is to prepare students to become pharmacists and pharmaceutical.

Innovation themes and landscape Paul Hellewell Director of Research & Innovation Faculty of Medicine, Dentistry & Health.

European Donation & Transplant Coordination Organisation The Donation & Procurement Section of ESOT and

RMIT University© 1 Health Innovations Research Institute (HIRi) Translating fundamental science into.

1 International Society for Pharmacoeconomics and Outcomes Research Student Network Educational Teleconference Thursday, September 24 th —3pm CST.

BBSRC future research priorities Professor Nigel Brown Director of Science and Technology Group.

Procurement & Distribution Interest Group Symposium 10 th June 2010 Beth Loudon – Business Development Manager.

Healthcare Scientists Leading Science in Health Jane Blower East Midlands SHA December 2011.

Integrating BME Design with Entrepreneurship Lance Kam Department of Biomedical Engineering Columbia University September 26, 2007.

Promotions on the Physician Scientist/Basic Science Investigator Track Larry L. Swift, Ph.D. Vice Chair for Faculty Affairs Department of Pathology, Microbiology.

Royal Society of Chemistry Food Group Vision & Mission June 2015.

Building Effective Community-Academic Partnerships to Improve Health: Lessons From the Field Cheryl A. Maurana, Ph.D. Senior Associate Dean for Public.

Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.

AACN – Manatt Study In February 2015, the AACN Board of Directors commissioned Manatt Health to conduct a study on how to position academic nursing to.

The Academy campaigns for the development, protection and promotion of careers for academics in the biomedical sciences and encourages good practice and.

David M. Deci, M.D. Director Office of Medical Student Education Associate Professor, Department of Family Medicine University of Wisconsin School of Medicine.

                 HTA: political and ethical perspectives Presentation to Forum on Pharmaceutical Policy in the Enlarged Europe at 7 th.

© UEG Presentation by Towards more coordination in health research: a report on the UEG research symposium 16/11/2012 Michael Manns General Assembly.

Independent Living Innovation Platform 04/03/15 Hazel Harper ILIP Programme Manager Innovate UK.

HEALTHGRAIN Forum  Mission To promote science based concepts fully unlocking the health promoting potential in the entire grain processing chain to obtain.

Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.

1 UK Council for Science and Technology Two themes 1.The CST itself – who we are and how we operate 2.Our innovation agenda.

H o n o r a r y M e m b e r s h i p Prof. David Kerr.

A national stakeholder roundtable

The mission of the Tri-Institutional MD-PhD Program is to educate and train physician-scientists, who are prepared to bridge the gap between laboratory.

Academy of Pharmaceutical Sciences

Innovation for Healthier Americans

Biography Assistant Vice Chancellor for Commercial Translation in the Health Sciences Visiting Associate Professor, Department of Biomedical Informatics.

Geriatric Medicine Society

FP7 Experience (Collaborative Project Application)

Maximizing the value and the impact of health research in Europe

2016 Strategy Review update

Trial Funding and Engagement: The NIH Sponsored CTSA Program

Royal Society of Chemistry Food Group

Presentation transcript:

Industry Symposium World Congress Tissue Engineering and Regenerative Medicine International Society Vienna, Austria September 5-8, 2012 Organized by TERMIS-AM and TERMIS-EU Industry Committees

TERMIS-AM Industry Committee Established 2009 Mission –Support commercialization in Tissue Engineering/Regenerative Medicine (TE/RM) Goals –Define and address obstacles/hurdles to product commercialization –Promote collaborations to build a viable TE/RM industry Members –Kiki B. Hellman, PhD; The Hellman Group. LLC; Chair –Timothy A. Bertram, DMV, PhD; Tengion –Peter C. Johnson, MD; Avery Dennison –Mark Van Dyke, PhD; Wake Forest University Health Sciences –Bill Tawil, PhD; Baxter Biosurgery 2

TERMIS-EU Industry Committee Established 2011 Mission –Motivate translation of academic research into commercial products, in Tissue Engineering/Regenerative Medicine (TE/RM) –Connect the scientific & clinical communities with TE/RM industries Goals –Give answers to critical questions, paving the road of TE/RM commercial translation, by key stakeholders, from past experiences –Promote academia–industry meetings & partnerships for more effective commercial translation in TE/RM Members –Yves Bayon, PhD; Covidien – Sofradim Production; Chair –Simon Ellison, MBA; NHS Blood & Transplant –John Barry, PhD; Baxter Innovations –Paul Stroemer, PhD, Reneuron –Chris Mason, PhD; University College of London –Alain Vertes, PhD; London Business School Sloan Fellow 3

4 Partnership, the key for successful translation of Regenerative Products World CongressTERMIS Organized by TERMIS-AM and TERMIS-EU Industry Committees Industry Symposium

SESSION 1: “Commercialization of Regenerative Products: The Academe/Industry Partnership” World Congress Tissue Engineering and Regenerative Medicine International Society Vienna, Austria September 5-8, 2012 Organized by TERMIS-AM and TERMIS-EU Industry Committees

Commercialization of Regenerative Products: The Academe/Industry Partnership Organizers: TERMIS-AM & TERMIS-EU Industry Committees Main Goals: to learn from past academia-industry collaborative experiences in TE/RM commercial development to enable academia and industry to understand how best to work together and identify individual collaborations that can rapidly move forward. 6

Commercialization of Regenerative Products: The Academe/Industry Partnership 7 9:05 – 9:20 Vienna/Austria - From a Strong Biomedical Tradition to a Future of Innovation and Patient Care Ehrlich H, Baxter Bioscience, Austria 9:20 – 9:40 Commercialization of regenerative medicine products: the academia-industry partnership Vertès A, London Business School, Sloan Fellowship, UK 9:40 – 10:00 Commercializing regenerative medicine therapeutics and sustaining a successful business Arshad A, Scientia Advisors, USA 10:00 – 10:15 Translating academic concepts to commercial medical products: A complex academic, industrial partnership Coury A, Consultant, USA 10:15 – 10:30 Successful translation of academic research using combinations of mesenchymal stromal cells with pharmaceutical agents for clinical applications in regenerative medicine Ghosh P, Mesoblast Ltd, Australia